ANESTOCIL
GROUPEMENT PHARMACEUTIQUE ALGERIEN
Identification
- Active ingredient (INN)
- OXYBUPROCAINE
- Internal code
- 17 A 001
- Country of Origin
- Algeria
- Pharmaceutical form
- Eye Drops Solution
- Prescription List
- Highly Regulated (List I)
- Packaging
- flacon/10ml
DAWA Clinical Workbench v2.0
Information may not be accurate. Always consult a physician, pharmacist, or specialist before acting on any data shown here.
Description
Oxybuprocaine (also known as Benoxinate) is a local anesthetic, which is used especially in ophthalmology and otolaryngology.
Oxybuprocaine binds to sodium channels and reversibly stabilizes the neuronal membrane which decreases its permeability to sodium ions.
Indications
Used to temporarily numb the front surface of the eye so that the eye pressure can be measured or a foreign body removed.
Pharmacodynamics
Oxybuprocaine is a local anaesthetic.
It may be less irritating than tetracaine, and the onset and duration of action are similar to tetracaine.
Adverse Effects
Improve decision support & research outcomes With structured adverse effects data, including: blackbox warnings, adverse reactions, warning & precautions, & incidence rates.
View sample adverse effects data in our new Data Library! See the data Improve decision support & research outcomes with our structured adverse effects data.